EDRF-formation increases cGMP-levels in cultured endothelial cells.
Schmidt
K
K
Department of Pharmacodynamics and Toxicology, University Graz, Austria.
Graier
W F
WF
Kukovetz
W R
WR
D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D001920:Bradykinin / Q000494:pharmacology; D000001:Calcimycin / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism / Q000494:pharmacology; D002172:Canavanine / Q000494:pharmacology; D002417:Cattle; D002478:Cells, Cultured; D006152:Cyclic GMP / Q000096:biosynthesis*; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D004789:Enzyme Activation; D006072:Gossypol / Q000494:pharmacology; D006162:Guanylate Cyclase / Q000378:metabolism; D008954:Models, Biological; D009569:Nitric Oxide / Q000096:biosynthesis* / Q000378:metabolism; D015290:Second Messenger Systems
D009569:Nitric Oxide; D000001:Calcimycin; D002172:Canavanine; D000255:Adenosine Triphosphate; D006162:Guanylate Cyclase; D006152:Cyclic GMP; D006072:Gossypol; D001920:Bradykinin; D002118:Calcium